292 related articles for article (PubMed ID: 8828069)
1. [Optimum dose study of cefozopran in the pediatric field].
Fujii R; Sunakawa K; Sato Y; Yokota T; Yoshimura K; Kondoh Y; Kawaoi Y; Terashima I; Meguro H; Niinou K; Toyonaga Y; Ishihara T; Iwai N; Nakamura H; Kuno K; Miyajima Y; Sakurai M; Itoh M; Kawasaki H; Suga S; Kamiya H; Fujiwara T; Inui T; Taniguchi K; Nakayama M
Jpn J Antibiot; 1996 Jul; 49(7):663-77. PubMed ID: 8828069
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and clinical effects of cefozopran in pediatric patients.
Fujii R; Abe T; Tajima T; Terashima I; Meguro H
Jpn J Antibiot; 1996 Jan; 49(1):17-33. PubMed ID: 8851304
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetic, bacteriological and clinical studies on cefozopran in the pediatric field].
Motohiro T; Handa S; Yamada S; Sasaki H; Oki S; Yoshinaga Y; Oda K; Aramaki M; Sakata Y; Yamashita F
Jpn J Antibiot; 1994 Nov; 47(11):1589-611. PubMed ID: 7853690
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetic and clinical studies with cefozopran in the pediatric field. Pediatric Study Group of Cefozopran].
Fujii R; Abe T; Tajima T; Terashima I; Meguro H; Nakazawa S; Sato H; Niinou K; Sunakawa K; Yokota T
Jpn J Antibiot; 1994 Jan; 47(1):102-23. PubMed ID: 8114268
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetic, bacteriological and clinical studies on cefozopran in neonates and premature infants. A study of cefozopran in the perinatal co-research group].
Fujii R; Okuno A; Fujita K; Kakuya F; Maruyama S; Sakata H; Inyaku F; Abe T; Hashira S; Nakazato Y; Sugiura M; Tajima T; Nagai S; Funamoto N; Sugimori S; Nishimura S; Yoshimura K; Kondoh Y; Kawaoi Y; Terashima I; Meguro H; Takeuchi Y; Kantake M; Sunakawa K; Yagisawa M
Jpn J Antibiot; 1996 Jul; 49(7):678-702. PubMed ID: 8828070
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacokinetic and clinical studies on cefozopran in the field of pediatrics].
Kaino Y; Kida K; Matsuda H
Jpn J Antibiot; 1994 Nov; 47(11):1565-75. PubMed ID: 7853687
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetic, bacteriological and clinical studies on cefozopran in children].
Tajima T; Kondo Y; Negishi S; Kawashima S; Hagiwara N; Iizuka T; Kubota K; Abe T
Jpn J Antibiot; 1994 Nov; 47(11):1457-63. PubMed ID: 7853676
[TBL] [Abstract][Full Text] [Related]
8. [Studies on cefozopran in the pediatric field].
Niinou K; Sato H
Jpn J Antibiot; 1994 Nov; 47(11):1473-84. PubMed ID: 7853678
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetic and clinical studies with cefluprenam in the pediatric field. Pediatric Study Group of Gefluprenam].
Fujii R; Abe T; Tajima T; Kobayashi M; Terashima I; Meguro H; Sunakawa K; Yokota T; Akita H; Kusumoto Y; Iwata S; Satoh Y; Toyonaga Y; Ishihara T; Nakamura H; Iwai N; Nakamura H; Kuno K; Katoh T; Ogawa A; Itomi K; Okumura A; Hayakawa F; Takahashi H; Etoh M
Jpn J Antibiot; 1997 Jul; 50(7):597-621. PubMed ID: 9743906
[TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of a new parenteral cephem, cefozopran, in children].
Taniuchi S; Higashino H; Takaya J; Ishizaki Y; Kino M; Man W; Kobayashi Y
Jpn J Antibiot; 1994 Nov; 47(11):1553-8. PubMed ID: 7853685
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetic and clinical evaluation of cefozopran in the pediatric field].
Toyonaga Y; Ishihara T; Hatakeyama K; Sano T; Kawamura K; Seo K; Nakamura H
Jpn J Antibiot; 1994 Nov; 47(11):1495-513. PubMed ID: 7853680
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetic and clinical studies on cefozopran in pediatrics].
Akita H; Sato Y; Iwata S; Yokota T; Sunakawa K
Jpn J Antibiot; 1994 Nov; 47(11):1485-94. PubMed ID: 7853679
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetic, bacteriological and clinical studies on cefozopran in neonates].
Abe T; Sugiura M; Nakazato Y; Hashira S; Yoshimura K; Kondoh Y; Kawaoi Y; Tajima T; Nagai S; Funamoto N; Sugimori S; Nishimura S
Jpn J Antibiot; 1997 Dec; 50(12):936-44. PubMed ID: 9545670
[TBL] [Abstract][Full Text] [Related]
14. [Fundamental and clinical evaluation of cefozopran in low birth weight infants and neonates].
Sato Y; Sunakawa K; Akita H; Iwata S; Yokota T; Kusumoto Y
Jpn J Antibiot; 1997 Dec; 50(12):917-35. PubMed ID: 9545669
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacokinetic and clinical evaluation of cefozopran in the pediatric field].
Iwai N; Nakamura H; Miyazu M; Watanabe Y; Taneda Y
Jpn J Antibiot; 1994 Nov; 47(11):1521-35. PubMed ID: 7853682
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetic and clinical studies of cefozopran in the field of pediatrics].
Kuno K; Ogawa A; Hayakawa F; Takahashi H; Kondo M; Okumura A
Jpn J Antibiot; 1994 Nov; 47(11):1514-20. PubMed ID: 7853681
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetic and clinical evaluation of cefozopran in premature and newborn patients].
Motohiro T; Sakata Y; Nagai K; Morita J; Takagishi T; Matsuo Y; Hashimoto T; Yoshinaga Y; Hayashi M; Toyota A; Fujimoto T; Wada M; Kamizono S
Jpn J Antibiot; 1997 Dec; 50(12):953-66. PubMed ID: 9545672
[TBL] [Abstract][Full Text] [Related]
18. [Bacteriological, pharmacokinetic and clinical evaluations of cefpirome sulfate in the pediatric field. Pediatric Study Group of Cefpirome].
Fujii R; Abe T; Meguro H; Tajima T; Nakazawa S; Sato H; Hirama Y; Narita A; Matsumoto K; Nakazawa S
Jpn J Antibiot; 1991 Jan; 44(1):84-109. PubMed ID: 2041150
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetic and clinical evaluation of cefozopran in newborn patients].
Tsuji Y; Fukuda M; Tomimasu K; Yoshinaga M; Takayanagi T; Nakashita S; Kusumoto T; Tanaka H; Hayashi K
Jpn J Antibiot; 1997 Dec; 50(12):967-74. PubMed ID: 9545673
[TBL] [Abstract][Full Text] [Related]
20. [Clinical studies on cefozopran in pediatrics].
Morita H; Fujieda M; Morisawa Y; Arai J; Shinohara M; Hosokawa T; Nagao A; Watanabe S; Maeda H; Takeda K
Jpn J Antibiot; 1994 Nov; 47(11):1576-81. PubMed ID: 7853688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
